MGMayna S. Gomide

Mayna S. Gomide

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Mayna S. Gomide has a total of 17 co-authors. Here are the top co-authors by number of shared publications:

  • André M. Murad

    Brazilian Agriculture Research Corporation - Embrapa - Genetic Resources and Biotechnology - CENARGEN, Brasília, 70770917, DF, Brazil

    1 shared publication
  • Cintia Gomez Limia

    Demeetra AgBio Lexington Kentucky USA

    1 shared publication
  • Cristiano Lacorte

    Brazilian Agriculture Research Corporation - Embrapa - Genetic Resources and Biotechnology - CENARGEN, Brasília, 70770917, DF, Brazil

    1 shared publication
  • Cíntia Marques Coelho

    Laboratory of Synthetic Biology, Center for Molecular Biotechnology (C-Biotech), University of Brasília Science and Technology Park (PCTec), Asa Norte, Brasília-DF 70910-900, Brazil

    1 shared publication
  • Eduardo O. Melo

    Brazilian Agriculture Research Corporation - Embrapa - Genetic Resources and Biotechnology - CENARGEN, Brasília, 70770917, DF, Brazil

    1 shared publication
  • Elibio Rech

    Embrapa Genetic Resources and Biotechnology, National Institute of Science and Technology - Synthetic Biology, Distrito Federal, Brasília, Brazil.

    1 shared publication

Latest Publications

  • Open Access

    Genetic switches designed for eukaryotic cells and controlled by serine integrases

    by Mayna S. Gomide, Thais T. Sales, Luciana R. C. Barros, Cintia G. Limia, Marco A. de Oliveira, Lilian H. Florentino, Leila M. G. Barros, Maria L. Robledo, Gustavo P. C. José, Mariana S. M. Almeida, et al.

    Recently, new serine integrases have been identified, increasing the possibility of scaling up genomic modulation tools. Here, we describe the use of unidirectional genetic switches to evaluate the functionality of six serine integrases in different eukaryotic systems: the HEK 293T cell lineage, bovine fibroblasts and plant protoplasts. Moreover, integrase activity was also tested in human cell types of therapeutic interest: peripheral blood mononuclear cells (PBMCs), neural stem cells (NSCs) and undifferentiated embryonic stem (ES) cells. The switches were composed of plasmids designed to flip two different genetic parts driven by serine integrases. Cell-based assays were evaluated by measurement of EGFP fluorescence and by molecular analysis of attL/attR sites formation after integrase functionality. Our results demonstrate that all the integrases were capable of inverting the targeted DNA sequences, exhibiting distinct performances based on the cell type or the switchable genetic sequence. These results should support the development of tunable genetic circuits to regulate eukaryotic gene expression.